-
EP1503783
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1503783
| EP1503783 - A COMBINATION PRODUCT COMPRISING AN ANTI-COAGULANT AND ANTI-ARRHYTHMIC OXABISPIDENES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.02.2008 Database last updated on 26.06.2024 | Most recent event Tooltip | 29.02.2008 | Application deemed to be withdrawn | published on 02.04.2008 [2008/14] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2005/06] | Inventor(s) | 01 /
ROTH-ROSENDAHL, Ann-Charlotte AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | 02 /
SVERNHAGE, Elisabeth AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | [2005/06] | Application number, filing date | 03723588.4 | 05.05.2003 | [2005/06] | WO2003SE00719 | Priority number, date | SE20020001374 | 06.05.2002 Original published format: SE 0201374 | [2005/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03092720 | Date: | 13.11.2003 | Language: | EN | [2003/46] | Type: | A1 Application with search report | No.: | EP1503783 | Date: | 09.02.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.11.2003 takes the place of the publication of the European patent application. | [2005/06] | Search report(s) | International search report - published on: | SE | 13.11.2003 | Classification | IPC: | A61K38/06, A61K31/5395, A61P7/02 | [2005/06] | CPC: |
A61K31/5395 (EP,KR,US);
A61K38/06 (KR);
A61K38/16 (KR);
A61K45/06 (EP,US);
A61P43/00 (EP);
A61P7/02 (EP);
| C-Set: |
A61K31/5395, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/06] | Extension states | AL | 06.12.2004 | LT | 06.12.2004 | LV | 06.12.2004 | MK | 06.12.2004 | Title | German: | KOMBINATIONSPRODUKT MIT EINEM ANTIKOAGULANS UND ANTIARRHYTHMISCHEN OXABISPIDENEN | [2005/06] | English: | A COMBINATION PRODUCT COMPRISING AN ANTI-COAGULANT AND ANTI-ARRHYTHMIC OXABISPIDENES | [2005/06] | French: | PRODUIT MIXTE CONTENANT UN ANTICOAGULANT ET DES OXABISPIDINES ANTI-ARYTHMISANTES | [2005/06] | Entry into regional phase | 06.12.2004 | National basic fee paid | 06.12.2004 | Designation fee(s) paid | 06.12.2004 | Examination fee paid | Examination procedure | 17.11.2003 | Request for preliminary examination filed International Preliminary Examining Authority: SE | 06.12.2004 | Examination requested [2005/06] | 23.05.2007 | Despatch of a communication from the examining division (Time limit: M04) | 03.10.2007 | Application deemed to be withdrawn, date of legal effect [2008/14] | 13.11.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2008/14] | Fees paid | Renewal fee | 31.05.2005 | Renewal fee patent year 03 | 31.05.2006 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.05.2007 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO0128992 (ASTRAZENECA AB [SE], et al); | [YP]WO0236157 (ASTRAZENECA AB [SE], et al); | [Y] - HAUPTMANN J., "Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs", EUR. J. CLIN. PHARMACOL., (2002), vol. 57, pages 751 - 758, XP002967335 DOI: http://dx.doi.org/10.1007/s00228-001-0392-7 |